Results 41 to 50 of about 166,329 (303)

PARP around the Clock [PDF]

open access: yesCell, 2010
Cells possess internal ∼24 hr or circadian clocks that synchronize physiological processes with daily cycles of light and nutrient availability. In this issue, Asher et al. (2010) find that PARP-1 (poly(ADP-ribose) polymerase 1) modifies components of the clock machinery in response to feeding, providing a mechanism for how metabolic rhythms coordinate
Kumar, Vivek, Takahashi, Joseph S.
openaire   +2 more sources

Never tear us a-PARP: Dealing with DNA lesions during mitosis

open access: yesMolecular & Cellular Oncology, 2018
Tumors defective in homologous recombination (HR) are highly sensitive to poly ADP-ribose polymerase (PARP) inhibition, however the cell biological mechanisms underlying this synthetic lethality remain elusive.
Pepijn M. Schoonen   +1 more
doaj   +1 more source

Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization

open access: yesFrontiers in Oncology, 2023
Polyadenosine diphosphate-ribose polymerase (PARP) is a key modifying enzyme in cells, which participates in single-strand break repair and indirectly affects double-strand break repair.
Yi Zhang   +6 more
doaj   +1 more source

Inhibition of Poly(ADP-Ribose) polymerase enhances the toxicity of 131I-Metaiodobenzylguanidine/Topotecan combination therapy to cells and xenografts that express the noradrenaline transporter [PDF]

open access: yes, 2012
Targeted radiotherapy using [131I]meta-iodobenzylguanidine ([131I]MIBG) has produced remissions in some neuroblastoma patients. We previously reported that combining [131I]MIBG with the topoisomerase I (Topo-I) inhibitor topotecan induced long-term DNA ...
Babich, John W   +7 more
core   +1 more source

Defective DNA repair mechanisms in prostate cancer: impact of olaparib [PDF]

open access: yes, 2017
The field of prostate oncology has continued to change dramatically. It has truly become a field that is intensely linked to molecular genetic alterations, especially DNA-repair defects.
De Felice, Francesca   +4 more
core   +2 more sources

PARP inhibitors and more

open access: yesJournal of the Turkish German Gynecological Association, 2015
Polyadenosine diphosphate (ADP) ribose polymerase (PARP) lends a panoramic view to the inner mystery of protection of integrity of deoxyribonucleic acid (DNA) in a cell genome. They are a balancing part of an even more dynamic equilibrium of normalcy against daily assaults.
Chinmoy K, Bose, Nirban, Basu
openaire   +2 more sources

Are PARPs promiscuous?

open access: yesBioscience Reports, 2022
Abstract Post-translational modifications exist in different varieties to regulate diverse characteristics of their substrates, ultimately leading to maintenance of cell health. The enzymes of the intracellular poly(ADP-ribose) polymerase (PARP) family can transfer either a single ADP-ribose to targets, in a reaction called mono(ADP ...
Karla L.H. Feijs, Roko Žaja
openaire   +3 more sources

Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities

open access: yesNeurobiology of Disease, 2023
Poly (ADP-ribose) polymerase-1 (PARP-1) is the most extensively studied member of the PARP superfamily, with its primary function being the facilitation of DNA damage repair processes.
Xiaoxue Xu, Bowen Sun, Chuansheng Zhao
doaj   +1 more source

Clinical relevance of endoscopic peri-appendiceal red patch in ulcerative colitis patients

open access: yesTherapeutic Advances in Gastroenterology, 2022
Background: Increasing evidence is suggesting appendectomy as an alternative treatment for ulcerative colitis (UC), especially in case of histological appendiceal inflammation.
Maud A. Reijntjes   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy